Drug

MWN109 clinical trials

studies test it: 11
open now: 3
in phase 3: 1
first study started: 2024

Keep track of what changes. Save the MWN109 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

MWN109 1: 7
MWN109 2: 7
MWN109 3: 6
MWN109 4: 3
MWN109 tablet: 2

Development codes

MWN109: 1

Studies by the year they started

11 studies that test it; most in 2025 (5)

Studies that test MWN109, by start year
Year	Studies
2024	1
2025	5
2026	5

By phase

A phase 1/2 study counts in both.

Phase 1: 5
Phase 2: 5
Phase 3: 1

What it is tested for

Each study’s main condition, where its own words name it.

Obesity: 7
Diabetes Mellitus, Type 2: 2

Who runs them

Industry 11 · Other 0

Shanghai Minwei Biotechnology Co., Ltd (11)

Studies

Open first, then newest update. How each study uses MWN109 is read from its arms, and is right about nine times in ten.

Testing it · 11

Phase 2 Clinical Study of MWN109 Tablets in Participants With Type 2 Diabetes MellitusRecruitingPhase 2Shanghai Minwei Biotechnology Co., LtdNCT07801820Written as MWN109 1
Phase 3 Study of MWN109 Injection in Participants With Overweight or ObesityNot yet recruitingPhase 3Shanghai Minwei Biotechnology Co., LtdNCT07778693Written as MWN109 1
A Study to Evaluate MWN109 Tablets in Healthy Adult ParticipantsRecruitingPhase 1Shanghai Minwei Biotechnology Co., LtdNCT06938269Written as MWN109 tablet
Phase 2 Study of MWN109 Tablet for Weight-Loss Maintenance in Participants With Overweight or ObesityActive, not recruitingPhase 2Shanghai Minwei Biotechnology Co., LtdNCT07804797Written as MWN109 1
A Study to Evaluate Different Administration Conditions and the Food Effect of MWN109 Tablets in Chinese ParticipantsCompletedPhase 1Shanghai Minwei Biotechnology Co., LtdNCT07801326Written as MWN109 Tablets
Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With OverweightActive, not recruitingPhase 2Shanghai Minwei Biotechnology Co., LtdNCT07791537Written as MWN109 1
Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or ObesityCompletedPhase 1Shanghai Minwei Biotechnology Co., LtdNCT07787728Written as MWN109 1
Phase 2 Study of MWN109 Tablet in Participants With Overweight or ObesityCompletedPhase 2Shanghai Minwei Biotechnology Co., LtdNCT07791524Written as MWN109 1
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or ObesityCompletedPhase 2Shanghai Minwei Biotechnology Co., LtdNCT07791654Written as MWN109 1
Phase I Clinical Study of MWN109 Tablets in Healthy Chinese ParticipantsCompletedPhase 1Shanghai Minwei Biotechnology Co., LtdNCT07787611Written as MWN109 tablet
Phase 1 Clinical Study of MWN109 Injection in Healthy Chinese VolunteersCompletedPhase 1Shanghai Minwei Biotechnology Co., LtdNCT07787624Written as MWN109